CRYPTIVAX

Active chemical ingredients for use in the manufacture of anti-cancer therapeutics and vaccines; antibodies for scientific purposes; nucleotides for scientific and research use; Chemicals, reagents and substances being peptides, nucleic acids and buffers for medical research purposes; proteins, namely arrays, monoclonal antibodies and enzymes for scientific and research use

Immunoassay reagents for medical use; Pharmaceutical products for the prevention and treatment of cancer; vaccines for the treatment of cancer; vaccines for the prevention of cancer; tumor antigens for medical use; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; vaccines for regulating the immune system; pharmaceutical preparations for regulating the immune system; proteins with diagnostic and therapeutic uses, namely arrays and solutions of proteins; Antibodies for medical purposes; vaccines for the prevention and treatment of immune system related diseases and disorders

Research and development in the field of cancer; research and development in the field of immunology; scientific research for medical purposes in the field of oncology; scientific research for medical purposes in the field of immunology; Biological research services; Pharmaceutical research services; pharmaceutical, biologic and immunological drug and vaccine development services; providing information and data relating to oncology and immunology; advisory and consultancy services related to oncology and immunology